2024
Quality of life among residents of informal urban settlements during the COVID-19 pandemic in Salvador, Brazil
Mogaji H, Nery N, Argibay H, Cruz J, Carneiro I, Lustosa R, Ko A, Costa F, Begon M, Khalil H. Quality of life among residents of informal urban settlements during the COVID-19 pandemic in Salvador, Brazil. BMJ Public Health 2024, 2: e000572. DOI: 10.1136/bmjph-2023-000572.Peer-Reviewed Original ResearchHealth-related quality of lifePhysical health scoresHealth scoresQuality of lifeHealth-related quality of life of residentsCross-sectional analysis of dataMental health scoresHealth-related qualityResults Most participantsMixed-effects regression modelsCross-sectional analysisCOVID-19 pandemicOlder age groupsPhysical healthOlder adultsDisadvantaged populationsOlder participantsMental challengesFood insecuritySlum communitiesMarginalised populationsCity of SalvadorAged 5Analysis of dataCreation of economic opportunities
2023
Age-dependent impairment in antibody responses elicited by a homologous CoronaVac booster dose
Filardi B, Monteiro V, Schwartzmann P, do Prado Martins V, Zucca L, Baiocchi G, Malik A, Silva J, Hahn A, Chen N, Pham K, Pérez-Then E, Miric M, Brache V, Cochon L, Larocca R, Della Rosa Mendez R, Silveira D, Pinto A, Croda J, Yildirim I, Omer S, Ko A, Vermund S, Grubaugh N, Iwasaki A, Lucas C, Initiative Y, Vogels C, Breban M, Koch T, Chaguza C, Tikhonova I, Castaldi C, Mane S, De Kumar B, Ferguson D, Kerantzas N, Peaper D, Landry M, Schulz W. Age-dependent impairment in antibody responses elicited by a homologous CoronaVac booster dose. Science Translational Medicine 2023, 15: eade6023. PMID: 36791210, DOI: 10.1126/scitranslmed.ade6023.Peer-Reviewed Original ResearchConceptsBooster doseAntibody responseNeutralization titersVirus-specific IgG titersOlder adultsAntiviral humoral immunityPlasma antibody responsesHigh-risk populationSARS-CoV-2 spikeYears of ageAge-dependent impairmentHeterologous regimensBooster dosesBooster vaccineCoronaVac vaccineIgG titersProtective immunityHumoral immunityHumoral responseCoronaVacOmicron waveBooster strategyAge groupsEarly controlVaccine